Confused About FDA Drug Approvals? Here’s What Every Pharma Professional Should Know
Every year, dozens of innovative medicines receive special FDA designations that can speed parts of the development and review process for …
Life Sciences
Digital Therapeutics (DTx) in 2026: How Software Is Becoming the Next Prescription Medicine
Healthcare is entering a new digital era where software is becoming an important part of patient care. While medicines, medical devices, …
FDA Approves Historic Gene Therapy for Children—A New Milestone in Modern Medicine
The U.S. Food and Drug Administration (FDA) has approved the first gene therapy for young children with sickle cell disease, marking …
AI Is Revolutionizing Drug Discovery—Here’s Why Big Pharma Is Investing Billions
Artificial Intelligence (AI) is no longer just a buzzword in the technology sector—it has become one of the most important forces …
Microsoft AI for Healthcare in 2026: How Artificial Intelligence Is Transforming Hospitals, Pharma, and Drug Discovery
Artificial intelligence is rapidly reshaping healthcare, and Microsoft continues to expand its AI capabilities across hospitals, pharmaceutical research, clinical documentation, and …
Eli Lilly Expands U.S. Manufacturing in 2026: What It Means for GLP-1 Drugs, Pharma Jobs, and Healthcare Innovation
The demand for GLP-1 medicines used in diabetes care and, where approved, chronic weight management has grown rapidly in recent years. …
$10 Billion Pharma Deal Could Transform Rare Disease Treatments
The pharmaceutical industry has witnessed another major acquisition as Vertex Pharmaceuticals announced an agreement to acquire Crinetics Pharmaceuticals in a transaction …
Generic GLP-1 Drugs Could Change the Weight-Loss Market—FDA Begins Review
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …
FDA Approves Sanofi’s Wearable Cancer Drug Device—A Big Step for Cancer Care
The U.S. Food and Drug Administration (FDA) has approved a wearable injector version of Sanofi’s blood cancer medicine Sarclisa for eligible …
FDA Plans to Simplify Drug Manufacturer Registration—Here’s Why It Matters
The U.S. Food and Drug Administration (FDA) has proposed a new rule that could simplify registration requirements for certain drug manufacturers …